Interpace Biosciences, Inc. (IDXG)
USD 2.41
(-9.06%)
USD 2.41
(-9.06%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 13.02 Million USD | -18.51% |
| 2022 | 15.97 Million USD | -58.42% |
| 2021 | 38.42 Million USD | -15.88% |
| 2020 | 45.68 Million USD | -33.84% |
| 2019 | 69.05 Million USD | 42.54% |
| 2018 | 48.44 Million USD | -9.62% |
| 2017 | 53.59 Million USD | 28.29% |
| 2016 | 41.77 Million USD | -38.3% |
| 2015 | 67.71 Million USD | -41.58% |
| 2014 | 115.9 Million USD | 67.82% |
| 2013 | 69.06 Million USD | -11.96% |
| 2012 | 78.44 Million USD | -30.81% |
| 2011 | 113.37 Million USD | -8.85% |
| 2010 | 124.38 Million USD | 13.31% |
| 2009 | 109.77 Million USD | -26.34% |
| 2008 | 149.03 Million USD | -17.0% |
| 2007 | 179.55 Million USD | -10.95% |
| 2006 | 201.63 Million USD | 0.66% |
| 2005 | 200.3 Million USD | -10.86% |
| 2004 | 224.7 Million USD | 2.31% |
| 2003 | 219.62 Million USD | 15.02% |
| 2002 | 190.93 Million USD | -36.92% |
| 2001 | 302.67 Million USD | 12.01% |
| 2000 | 270.22 Million USD | 162.35% |
| 1999 | 103 Million USD | 47.35% |
| 1998 | 69.9 Million USD | 463.71% |
| 1997 | 12.4 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 12.14 Million USD | -6.75% |
| 2024 Q2 | 12.97 Million USD | 6.84% |
| 2023 FY | 13.02 Million USD | -18.51% |
| 2023 Q1 | 15.87 Million USD | -0.64% |
| 2023 Q3 | 14.25 Million USD | -10.61% |
| 2023 Q2 | 15.94 Million USD | 0.41% |
| 2023 Q4 | 13.02 Million USD | -8.62% |
| 2022 FY | 15.97 Million USD | -58.42% |
| 2022 Q2 | 35.48 Million USD | -7.48% |
| 2022 Q1 | 38.35 Million USD | -0.18% |
| 2022 Q3 | 15.29 Million USD | -56.91% |
| 2022 Q4 | 15.97 Million USD | 4.49% |
| 2021 Q4 | 38.42 Million USD | -4.66% |
| 2021 Q2 | 43.18 Million USD | -1.53% |
| 2021 Q3 | 40.3 Million USD | -6.66% |
| 2021 FY | 38.42 Million USD | -15.88% |
| 2021 Q1 | 43.85 Million USD | -3.99% |
| 2020 Q4 | 45.68 Million USD | -9.9% |
| 2020 Q3 | 50.7 Million USD | -35.36% |
| 2020 FY | 45.68 Million USD | -33.84% |
| 2020 Q1 | 78.51 Million USD | 13.7% |
| 2020 Q2 | 78.43 Million USD | -0.1% |
| 2019 Q2 | 50.33 Million USD | -7.45% |
| 2019 Q4 | 69.05 Million USD | -7.53% |
| 2019 Q1 | 54.38 Million USD | 12.26% |
| 2019 Q3 | 74.67 Million USD | 48.36% |
| 2019 FY | 69.05 Million USD | 42.54% |
| 2018 Q3 | 49.8 Million USD | -3.03% |
| 2018 FY | 48.44 Million USD | -9.62% |
| 2018 Q1 | 53.09 Million USD | -0.93% |
| 2018 Q2 | 51.35 Million USD | -3.28% |
| 2018 Q4 | 48.44 Million USD | -2.73% |
| 2017 FY | 53.59 Million USD | 28.29% |
| 2017 Q1 | 46.97 Million USD | 12.44% |
| 2017 Q3 | 50.39 Million USD | -6.24% |
| 2017 Q2 | 53.74 Million USD | 14.41% |
| 2017 Q4 | 53.59 Million USD | 6.36% |
| 2016 Q4 | 41.77 Million USD | -9.11% |
| 2016 FY | 41.77 Million USD | -38.3% |
| 2016 Q3 | 45.96 Million USD | -14.1% |
| 2016 Q2 | 53.51 Million USD | -5.75% |
| 2016 Q1 | 56.77 Million USD | -16.15% |
| 2015 Q2 | 107.57 Million USD | -4.47% |
| 2015 Q3 | 99.28 Million USD | -7.7% |
| 2015 Q4 | 67.71 Million USD | -31.8% |
| 2015 FY | 67.71 Million USD | -41.58% |
| 2015 Q1 | 112.61 Million USD | -2.84% |
| 2014 Q1 | 65.38 Million USD | -5.33% |
| 2014 Q4 | 115.9 Million USD | 86.26% |
| 2014 FY | 115.9 Million USD | 67.82% |
| 2014 Q3 | 62.22 Million USD | 4.66% |
| 2014 Q2 | 59.45 Million USD | -9.06% |
| 2013 Q1 | 82.79 Million USD | 5.55% |
| 2013 FY | 69.06 Million USD | -11.96% |
| 2013 Q2 | 77.27 Million USD | -6.67% |
| 2013 Q4 | 69.06 Million USD | -5.67% |
| 2013 Q3 | 73.21 Million USD | -5.26% |
| 2012 Q4 | 78.44 Million USD | -26.05% |
| 2012 FY | 78.44 Million USD | -30.81% |
| 2012 Q3 | 106.07 Million USD | 1.2% |
| 2012 Q2 | 104.81 Million USD | -3.78% |
| 2012 Q1 | 108.93 Million USD | -3.92% |
| 2011 Q4 | 113.37 Million USD | -8.72% |
| 2011 Q3 | 124.21 Million USD | 6.21% |
| 2011 Q1 | 121.71 Million USD | -2.15% |
| 2011 Q2 | 116.95 Million USD | -3.91% |
| 2011 FY | 113.37 Million USD | -8.85% |
| 2010 FY | 124.38 Million USD | 13.31% |
| 2010 Q4 | 124.38 Million USD | 8.32% |
| 2010 Q2 | 112.58 Million USD | 5.89% |
| 2010 Q3 | 114.83 Million USD | 2.0% |
| 2010 Q1 | 106.32 Million USD | -3.15% |
| 2009 Q1 | 133.43 Million USD | -10.47% |
| 2009 Q3 | 124.92 Million USD | -0.61% |
| 2009 Q4 | 109.77 Million USD | -12.13% |
| 2009 FY | 109.77 Million USD | -26.34% |
| 2009 Q2 | 125.69 Million USD | -5.8% |
| 2008 Q4 | 149.03 Million USD | -4.95% |
| 2008 Q2 | 166.29 Million USD | -3.27% |
| 2008 FY | 149.03 Million USD | -17.0% |
| 2008 Q1 | 171.91 Million USD | -4.26% |
| 2008 Q3 | 156.8 Million USD | -5.71% |
| 2007 Q1 | 190.08 Million USD | -5.73% |
| 2007 Q4 | 179.55 Million USD | 0.07% |
| 2007 Q3 | 179.42 Million USD | -3.19% |
| 2007 Q2 | 185.34 Million USD | -2.49% |
| 2007 FY | 179.55 Million USD | -10.95% |
| 2006 Q3 | 200.42 Million USD | -0.18% |
| 2006 FY | 201.63 Million USD | 0.66% |
| 2006 Q2 | 200.79 Million USD | 0.02% |
| 2006 Q4 | 201.63 Million USD | 0.6% |
| 2006 Q1 | 200.74 Million USD | 0.22% |
| 2005 FY | 200.3 Million USD | -10.86% |
| 2005 Q4 | 200.3 Million USD | -7.56% |
| 2005 Q3 | 216.67 Million USD | -1.06% |
| 2005 Q2 | 218.99 Million USD | 1.08% |
| 2005 Q1 | 216.65 Million USD | -3.58% |
| 2004 Q4 | 224.7 Million USD | 2.67% |
| 2004 Q3 | 218.86 Million USD | -2.02% |
| 2004 Q2 | 223.38 Million USD | -1.71% |
| 2004 Q1 | 227.26 Million USD | 3.48% |
| 2004 FY | 224.7 Million USD | 2.31% |
| 2003 Q4 | 219.62 Million USD | 10.69% |
| 2003 Q2 | 186.57 Million USD | 0.58% |
| 2003 FY | 219.62 Million USD | 15.02% |
| 2003 Q1 | 185.49 Million USD | -2.85% |
| 2003 Q3 | 198.4 Million USD | 6.34% |
| 2002 Q2 | 198.21 Million USD | -25.5% |
| 2002 Q1 | 266.06 Million USD | -12.09% |
| 2002 FY | 190.93 Million USD | -36.92% |
| 2002 Q4 | 190.93 Million USD | -3.8% |
| 2002 Q3 | 198.47 Million USD | 0.13% |
| 2001 Q2 | 312.48 Million USD | 2.06% |
| 2001 FY | 302.67 Million USD | 12.01% |
| 2001 Q4 | 302.67 Million USD | 1.41% |
| 2001 Q1 | 306.19 Million USD | 13.31% |
| 2001 Q3 | 298.45 Million USD | -4.49% |
| 2000 Q4 | 270.22 Million USD | 54.64% |
| 2000 FY | 270.22 Million USD | 162.35% |
| 2000 Q1 | 160.55 Million USD | 55.87% |
| 2000 Q2 | 170.37 Million USD | 6.12% |
| 2000 Q3 | 174.74 Million USD | 2.56% |
| 1999 Q4 | 103 Million USD | 18.25% |
| 1999 Q3 | 87.1 Million USD | -5.22% |
| 1999 FY | 103 Million USD | 47.35% |
| 1999 Q2 | 91.9 Million USD | 8.89% |
| 1999 Q1 | 84.4 Million USD | 20.74% |
| 1998 Q1 | 24.5 Million USD | 97.58% |
| 1998 Q3 | 65.1 Million USD | -0.15% |
| 1998 Q4 | 69.9 Million USD | 7.37% |
| 1998 Q2 | 65.2 Million USD | 166.12% |
| 1998 FY | 69.9 Million USD | 463.71% |
| 1997 FY | 12.4 Million USD | 0.0% |
| 1997 Q4 | 12.4 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -926.084% |
| Arrayit Corporation | 1 Million USD | -1201.594% |
| Atlantic International Corp. | 4.43 Million USD | -193.506% |
| Biocept, Inc. | 30.87 Million USD | 57.824% |
| Bioqual, Inc. | 56.58 Million USD | 76.99% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -5514.146% |
| DermTech, Inc. | 121.93 Million USD | 89.321% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.689% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 26.756% |
| iMD Companies, Inc. | 190.13 Thousand USD | -6748.22% |
| IDenta Corp. | 1.52 Million USD | -751.449% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | -57.794% |
| InVitro International | 1.53 Million USD | -748.823% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 51.483% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -563092.042% |
| Medical Imaging Corp. | 4.19 Million USD | -210.643% |
| NovelStem International Corp. | 2.25 Million USD | -477.544% |
| Optigenex Inc. | 1.88 Million USD | -589.566% |
| PharmChem, Inc. | 2.76 Million USD | -370.827% |
| Proteome Sciences plc | 14.58 Million USD | 10.73% |
| Response Genetics, Inc | 48.88 Million USD | 73.363% |
| Rennova Health, Inc. | 20.57 Million USD | 36.708% |
| RushNet, Inc. | 6.04 Million USD | -115.308% |
| ScreenPro Security Inc. | 1.26 Million USD | -932.299% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -2656.216% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -1758.412% |
| Todos Medical Ltd. | 15.26 Million USD | 14.711% |